Susquehanna Portfolio Strategies, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1996449 Bala Cynwyd, PA

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$45,166,665

+$32,132,609 QoQ

Shares Held

90,928

+211.5% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#181

of 1,732 holders

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Susquehanna Portfolio Strategies, LLC holds $399,265,861 across 121 Biotechnology names. VRTX ranks #1 (11.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	90,928	$45,166,665
2	MRNA	Moderna, Inc.	471,043	$32,987,141
3	CORT	Corcept Therapeutics Inc	211,017	$18,347,928
4	BBIO	BridgeBio Pharma, Inc.	226,869	$16,897,203
5	BMRN	Biomarin Pharmaceutical Inc	273,562	$15,653,217
6	HALO	Halozyme Therapeutics, Inc.	166,503	$13,032,189
7	EXEL	Exelixis, Inc.	229,749	$12,500,643
8	MDGL	Madrigal Pharmaceuticals, Inc.	22,003	$11,814,510

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,166,665	90,928	+211.5%	Shares	Sole	2026-08-14
2026-03-31	$13,034,056	29,189	0.0%	Shares	Sole	2026-05-15
2025-12-31	$13,233,125	29,189	+9.0%	Shares	Sole	2026-02-17
2025-09-30	$10,489,685	26,784	+4349.2%	Shares	Sole	2025-11-14
2024-09-30	$279,978	602	-50.1%	Shares	Defined	2024-11-14
2024-06-30	$565,276	1,206	-88.7%	Shares	Defined	2024-08-15
2024-03-31	$4,455,568	10,659	-88.6%	Shares	Defined	2024-05-07
2023-12-31	$37,913,196	93,178	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.